Brivaracetam Impurity 115 CAS CATO-C4X-2007115

Description

Compared with other compounds in its class, the molecular weight of 334.37 g/mol gives Brivaracetam Impurity 115 distinctive chromatographic separation conditions and mass-spectrometry parameter settings.

CATO supplies Brivaracetam Impurity 115 (CAS CATO-C4X-2007115), a pharmacopoeial impurity reference standard (molecular formula C11H22N2O3C3H4O4, MW 334.37 g/mol) used for the identification and quantification of trace impurities in APIs.

Based on its molecular formula C11H22N2O3C3H4O4, Brivaracetam Impurity 115 contains an amide group, a carboxylic acid group, a hydroxyl group, an ether linkage; these features give the compound characteristic absorption bands in UV spectroscopy. The molecular weight of 334.37 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).

This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.

As a certified reference material (CRM), Brivaracetam Impurity 115 meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.

Physical & Chemical Properties

Why CATO?

• ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
• 130,000+ catalog items in stock, COA supplied with every batch
• Worldwide shipping with full export documentation (HS code guidance available)
• Technical support: +86 18665070610 / Nicole.chen@cato-chem.com